Synapse Open Synapse
Biology

Flagship blends three biotech startups to form Etcelera

BioPharma Dive · · 3 min read

Etiome, Cellarity and Empress Therapeutics are being combined into one new AI-aided drugmaker claiming to possess the ability to better predict the way new medicines will fare in humans.

Latest from BioPharma Dive